TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 533,125 | 479,946 | 376,265 |
Financial expenses | 27,038 | 16,409 | 4,681 |
Earnings before taxes | 32,285 | 12,185 | 4,645 |
EBITDA | 95,536 | 53,824 | 32,624 |
Total assets | 1,342,796 | 2,269,605 | 0 |
Current assets | 363,339 | 1,252,368 | 820,270 |
Current liabilities | 201,164 | 1,118,356 | 639,958 |
Equity capital | 1,128,983 | 1,138,132 | 1,211,567 |
- share capital | 300,030 | 309,327 | 332,285 |
Employees (average) | 364 | 350 | 296 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.1% | 50.1% | |
Turnover per employee | 1,465 | 1,371 | 1,271 |
Profit as a percentage of turnover | 6.1% | 2.5% | 1.2% |
Return on assets (ROA) | 4.4% | 1.3% | |
Current ratio | 180.6% | 112.0% | 128.2% |
Return on equity (ROE) | 2.9% | 1.1% | 0.4% |
Change turnover | 67,603 | 129,677 | -34,537 |
Change turnover % | 15% | 37% | -8% |
Chg. No. of employees | 14 | 54 | 3 |
Chg. No. of employees % | 4% | 18% | 1% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.